4th Quarter - Report
WUXI BIOLOGICS USA LLC for WUXI BIOLOGICS USA LLC
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
Foreign entity interest: WuXi Biologics Ireland Limited, WuXi Biologics Investments Limited, WuXi Biologics (Cayman) Inc., WuXi Biologics (Hong Kong) Limited, and WuXi Biologics (Shanghai) Co., Ltd
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM AITCHISON | — |
| ELIZABETH STEELE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.